KLF6 and cancer: Notably, splicing of hMENA may improve the early diagnosis of breast cancer and clinical decision [104], whereas the balance between splicing variants of KLF6 and caspase-9 genes could be useful to predict the susceptibility of cancer cells to chemotherapy [129, 130].